Timeliness of adjuvant chemotherapy for stage III adenocarcinoma of the colon: A measure of quality of care

Clinical Colorectal Cancer

Volumn 12, Issue 4, 2013, Pages 275-279

  Yu, Steven ^a   Shabihkhani, Maryam ^a   Yang, Dongyun ^a   Thara, Eddie ^a   Senagore, Anthony ^a   Lenz, Heinz Josef ^a   Sadeghi, Sarmad ^a   Barzi, Afsaneh ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adjuvant therapy; Affordable Care Act; Colon cancer; Quality measure; Racial disparities

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COLON ADENOCARCINOMA; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PROBABILITY; RETROSPECTIVE STUDY; THERAPY DELAY; TREATMENT DURATION;

ADJUVANT THERAPY; AFFORDABLE CARE ACT; COLON CANCER; QUALITY MEASURE; RACIAL DISPARITIES;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84887264032     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2013.08.002     Document Type: Article

References (20)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. Fast Stats: an interactive tool for access to SEER cancer statistics. Available at: http://seer.cancer.gov/faststats/selections.php? Accessed May 25, 2013.
3. T. Andre, C. Boni, and M. Navarro Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 2009 3109 3116
4. G. Yothers, M.J. O'Connell, and C.J. Allegra Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses J Clin Oncol 29 2011 3768 3774
5. P.M. Czaykowski, S. Gill, and H.F. Kennecke Adjuvant chemotherapy for stage III colon cancer: does timing matter? Dis Colon Rectum 54 2011 1082 1089
6. D. Hershman, M.J. Hall, and X. Wang Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer Cancer 107 2006 2581 2588
7. I. Chau, A.R. Norman, and D. Cunningham A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer Ann Oncol 16 2005 549 557
8. J.J. Biagi, M.J. Raphael, and W.J. Mackillop Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis JAMA 305 2011 2335 2342
9. Colon Cancer Measures submitted by the CoC to the National Quality Forum (NQF) and endorsed by the NQF in April 2007. Available at: http://www.facs.org/ cancer/ncdb/colonmeasures.pdf. Accessed: February 1, 2013.
10. P. Gibbs, D. Handolias, and S. McLaughlin Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer Int Med J 38 2008 265 269
11. I. Ahmad, G. Anan, and R. Alvi Impact of timing of initiation of adjuvant chemotherapy on survival after resection of colorectal cancer J Clin Oncol 2007; ASCO Annual Meeting 18(suppl) 2007 4054
12. A.Y. Bedikian, H. Kantarjian, and R.S. Nelson Colorectal cancer in young adults South Med J 74 1981 920 924
13. A.J. Minardi Jr., K.M. Sittig, and G.B. Zibari Colorectal cancer in the young patient Am Surg 64 1998 849 853
14. J.B. O'Connell, M.A. Maggard, and J.H. Liu Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum 47 2004 2064 2069
15. S.A. Fedewa, E.M. Ward, and A.K. Stewart Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006 J Clin Oncol 28 2010 4135 4141
16. S. Bayraktar, U.D. Bayraktar, and C.M. Rocha-Lima Timing of adjuvant and neoadjuvant therapy in colorectal cancers Clin Colorectal Cancer 9 2010 144 149
17. W. Lee, R. Nelson, and B. Mailey Socioeconomic factors impact colon cancer outcomes in diverse patient populations J Gastrointest Surg 16 2012 692 704
18. J.Z. Ayanian, A.M. Zaslavsky, and C.S. Fuchs Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort J Clin Oncol 21 2003 1293 1300
19. R.D. Cress, S.A. Sabatino, and X.C. Wu Adjuvant chemotherapy for patients with stage III colon cancer: results from a CDC-NPCR patterns of care study Clin Med Oncol 3 2009 107 119
20. K. Naylor, J. Ward, and B.N. Polite Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review J Gen Intern Med 27 2012 1033 1046